Showing results (171-180 of 328) with videos related to
Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimenA D Ho, T Lipp, G Ehninger, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patientsG Pawelec, G Ehninger, H Schmidt, et al.Pneumologie (Stuttgart, Germany)|May 1, 1991
[Lung changes caused by Mycobacterium xenopi infection in a patient with bone marrow transplantation: problems in differential diagnosis]F W Busch, W Bautz, R Dierkesmann, et al.Bone Marrow Transplantation|March 13, 2001
Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor originU Platzbecker, K Klingel, C Thiede, et al.Onkologie|June 1, 1986
Mitoxantrone and VP-16 in refractory acute myelogenous leukemiaA D Ho, T Lipp, G Ehninger, et al.Annals of Hematology|January 1, 1993
Leukemic red bone marrow changes assessed by magnetic resonance imaging and localized 1H spectroscopyF Schick, H Einsele, H Bongers, et al.Stem Cells (Dayton, Ohio)|April 24, 1999
Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vesselsT Köhler, R Plettig, W Wetzstein, et al.British Journal of Haematology|February 13, 2001
Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemiaM Schaich, M Ritter, T Illmer, et al.British Journal of Haematology|February 15, 2002
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphomaR Naumann, A Vaic, B Beuthien-Baumann, et al.Leukemia|January 20, 2009
The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemiaH Seifert, B Mohr, C Thiede, et al.Pageof 33